Position in EXEL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$5,921,607
-$2,287,620 QoQ
Shares Held
138,065
-26.3% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vestcor Inc holds $67,387,677 across 32 Biotechnology names. EXEL ranks #5 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
34,019 | $15,190,844 | |
| 2 | INCY |
Incyte Corp
|
119,739 | $11,269,834 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
447,412 | $6,469,577 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
63,077 | $6,134,238 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
138,065 | $5,921,607 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
100,000 | $5,272,000 | |
| 7 | ACLX |
Arcellx, Inc.
|
19,578 | $2,247,945 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,319 | $1,759,897 |
All Filings in EXEL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,921,607 | 138,065 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $8,209,227 | 187,297 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $8,499,333 | 205,795 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,254,685 | 187,266 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $5,446,327 | 147,517 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,841,689 | 55,306 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,551,524 | 59,789 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,327,235 | 59,067 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,401,659 | 59,067 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,420,495 | 59,212 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,268,086 | 58,036 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $673,703 | 35,254 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $684,280 | 35,254 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $565,474 | 35,254 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $664,675 | 42,390 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $733,988 | 35,254 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $273,536 | 12,066 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $151,797 | 8,304 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $195,333 | 9,240 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $168,352 | 9,240 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $208,731 | 9,240 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $185,446 | 9,240 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $225,918 | 9,240 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $219,357 | 9,240 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||